Skip to main content
Dylan Steen, MD, Cardiology, Cincinnati, OH, University of Cincinnati Medical Center

DylanLauriSteenMD

Cardiology Cincinnati, OH

UC Associate Professor and Director of Clinical Trials and Population Health Research; Cardiologist and Researcher; and CEO/Co-Founder of High Enroll, the Research Enrollment Solution Designed for Clinicians and CRPs.

Dr. Steen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Steen's full profile

Already have an account?

Education & Training

  • Harvard School of Public Health
    Harvard School of Public HealthM.S., Epidemiology, 2011 - 2014
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Cardiovascular Disease, 2008 - 2011
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 2005
  • Cook College, Rutgers University
    Cook College, Rutgers UniversityB.S., Biochemistry, 1996 - 2000

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2014 - 2026
  • MA State Medical License
    MA State Medical License 2012 - 2014
  • VA State Medical License
    VA State Medical License 2011 - 2014
  • FL State Medical License
    FL State Medical License 2009 - 2013
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Senior Resident of the Year Jackson Memorial Hospital, 2008
  • Intern of the Year Jackson Memorial Hospital, 2006

Publications & Presentations

PubMed

Journal Articles

  • The Effect of Fasting Status on Lipids, Lipoproteins, and Inflammatory Biomarkers Assessed After Hospitalization for an Acute Coronary Syndrome: Insights from PROVE IT...  
    Dylan L Steen, Naseer Khan, Clinical Cardiology
  • Widening the Path and Window of Opportunity for FDA Approval of Non-Vitamin K Oral Anticoagulant Specific Antidotes and Reversal Agents  
    Patel S, Steen DL, Journal of Thrombosis and Thrombolysis, 1/15/2015
  • Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome: The SOLID-TIMI 52 Randomized Clinical Trial  
    O'Donoghue ML, Braunwald E, White HD, Steen DL, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wivio..., JAMA, 1/31/2014
  • Join now to see all

Abstracts/Posters

  • Prognostic Utility of Fibroblast Growth Factor-23 after an Acute Coronary Syndrome
    Udell JA, Morrow DA, Braunwald E, Cannon CP, Steen DL, Jarolim P, Lukas MA, Budaj A, Hamm C, Zhou J, Im K, Sabatine MS, O’Donoghue ML, ACC, 1/1/2015
  • Galectin-3 for Heart Failure Risk Stratification in Patients After ACS: Insights from the SOLID-TIMI 52 trial
    Magnani G, O’Donoghue ML, Braunwald E, Steen DL, Jarolim P, Lukas MA, White HD, Lewis B, de Winter RJ, Zhou J, Im K, Cannon CP, Morrow DA, AHA, 1/1/2015
  • Performance Reports and the Utilization of Guideline-Based Therapies in a Large Clinical Trial Population Enrolled after an Acute Coronary Syndrome: Insights from the...
    Steen DL, Cannon CP, Daga S, Lukas MA, Ophuis TO, Gratsiansky N, Crugnale S, Shannon J, O’Donoghue ML, ACC, 1/1/2015
  • Join now to see all

Other

Press Mentions

  • University of Cincinnati Study: Dietary Educa
    University of Cincinnati Study: Dietary EducaDecember 14th, 2022
  • UC Study: Dietary Education Leads to Healthier Lives
    UC Study: Dietary Education Leads to Healthier LivesDecember 13th, 2022
  • UC Study: Diet Ed Improves Health Outcomes
    UC Study: Diet Ed Improves Health OutcomesDecember 13th, 2022
  • Join now to see all

Hospital Affiliations